ALECENSA was able to shrink the size of tumors in nearly 80% of people with ALK+ mNSCLC. At the first assessment, the IRC evaluated the ability of ALECENSA to shrink the size of tumors in people with ALK+ mNSCLC. It is important to know that a complete response does not mean the cancer has been cured.
Additional Information
Payment Terms Western Union,
Port of DispatchInidia
Packaging DetailsBox
Delivery Time05-12days
Interested in this product? Ask for more details & Latest Price from seller
Member Since 3 Years
Nature of Business Exporter
GST No. 27AAACN6927A1ZP
For Buyer 
For Seller 
Help 
Vile Parle East, Mumbai, Maharashtra 
Send Enquiry